Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 30 July 1999:
Vol. 285. no. 5428, pp. 744 - 746
DOI: 10.1126/science.285.5428.744
Prev | Table of Contents | Next

Reports

Peptide Antagonists of the Human Estrogen Receptor

John D. Norris, 1 Lisa A. Paige, 2 Dale J. Christensen, 2 Ching-Yi Chang, 1 Maria R. Huacani, 1 Daju Fan, 1 Paul T. Hamilton, 2 Dana M. Fowlkes, 2 Donald P. McDonnell 1*

Estrogen receptor alpha  transcriptional activity is regulated by distinct conformational states that are the result of ligand binding. Phage display was used to identify peptides that interact specifically with either estradiol- or tamoxifen-activated estrogen receptor alpha . When these peptides were coexpressed with estrogen receptor alpha  in cells, they functioned as ligand-specific antagonists, indicating that estradiol-agonist and tamoxifen-partial agonist activities do not occur by the same mechanism. The ability to regulate estrogen receptor alpha  transcriptional activity by targeting sites outside of the ligand-binding pocket has implications for the development of estrogen receptor alpha  antagonists for the treatment of tamoxifen-refractory breast cancers.

1 Duke University Medical Center, Department of Pharmacology and Cancer Biology, Durham, NC 27710, USA.
2 Novalon Pharmaceutical Corporation, 4222 Emperor Boulevard, Suite 560, Durham, NC 27703, USA.
*   To whom correspondence should be addressed. E-mail: mcdon016{at}acpub.duke.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Selective Estrogen Receptor Modulators Decrease Reactive Astrogliosis in the Injured Brain: Effects of Aging and Prolonged Depletion of Ovarian Hormones.
G. Barreto, M. Santos-Galindo, Y. Diz-Chaves, O. Pernia, P. Carrero, I. Azcoitia, and L. M. Garcia-Segura (2009)
Endocrinology 150, 5010-5015
   Abstract »    Full Text »    PDF »
Nuclear Receptor-Coregulator Interaction Profiling Identifies TRIP3 as a Novel Peroxisome Proliferator-activated Receptor {gamma} Cofactor.
A. Koppen, R. Houtman, D. Pijnenburg, E. H. Jeninga, R. Ruijtenbeek, and E. Kalkhoven (2009)
Mol. Cell. Proteomics 8, 2212-2226
   Abstract »    Full Text »    PDF »
Two-state selection of conformation-specific antibodies.
J. Gao, S. S. Sidhu, and J. A. Wells (2009)
PNAS 106, 3071-3076
   Abstract »    Full Text »    PDF »
A Set of Time-Resolved Fluorescence Resonance Energy Transfer Assays for the Discovery of Inhibitors of Estrogen Receptor-Coactivator Binding.
J. R. Gunther, Yuhong Du, E. Rhoden, I. Lewis, B. Revennaugh, T. W. Moore, Sung Hoon Kim, R. Dingledine, Haian Fu, and J. A. Katzenellenbogen (2009)
J Biomol Screen 14, 181-193
   Abstract »    PDF »
Differential Biochemical and Cellular Actions of Premarin Estrogens: Distinct Pharmacology of Bazedoxifene-Conjugated Estrogens Combination.
T. J. Berrodin, K. C. N. Chang, B. S. Komm, L. P. Freedman, and S. Nagpal (2009)
Mol. Endocrinol. 23, 74-85
   Abstract »    Full Text »    PDF »
Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs.
S. Tapia-Gonzalez, P. Carrero, O. Pernia, L. M Garcia-Segura, and Y. Diz-Chaves (2008)
J. Endocrinol. 198, 219-230
   Abstract »    Full Text »    PDF »
27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator.
C. D. DuSell, M. Umetani, P. W. Shaul, D. J. Mangelsdorf, and D. P. McDonnell (2008)
Mol. Endocrinol. 22, 65-77
   Abstract »    Full Text »    PDF »
Definition of Functionally Important Mechanistic Differences among Selective Estrogen Receptor Down-regulators.
B. M. Wittmann, A. Sherk, and D. P. McDonnell (2007)
Cancer Res. 67, 9549-9560
   Abstract »    Full Text »    PDF »
The Nuclear Receptor-Coactivator Interaction Surface as a Target for Peptide Antagonists of the Peroxisome Proliferator-Activated Receptors.
N. B. Mettu, T. B. Stanley, M. A. Dwyer, M. S. Jansen, J. E. Allen, J. M. Hall, and D. P. McDonnell (2007)
Mol. Endocrinol. 21, 2361-2377
   Abstract »    Full Text »    PDF »
Coactivators PGC-1beta and SRC-1 Interact Functionally to Promote the Agonist Activity of the Selective Estrogen Receptor Modulator Tamoxifen.
D. Kressler, M. B. Hock, and A. Kralli (2007)
J. Biol. Chem. 282, 26897-26907
   Abstract »    Full Text »    PDF »
Estrogen Receptors: How Do They Signal and What Are Their Targets.
N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, et al. (2007)
Physiol Rev 87, 905-931
   Abstract »    Full Text »    PDF »
Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor {alpha}.
W. Zwart, A. Griekspoor, M. Rondaij, D. Verwoerd, J. Neefjes, and R. Michalides (2007)
Mol. Cancer Ther. 6, 1526-1533
   Abstract »    Full Text »    PDF »
Structural Insights into Corepressor Recognition by Antagonist-bound Estrogen Receptors.
N. Heldring, T. Pawson, D. McDonnell, E. Treuter, J.-A. Gustafsson, and A. C. W. Pike (2007)
J. Biol. Chem. 282, 10449-10455
   Abstract »    Full Text »    PDF »
Identification of Regions within the F Domain of the Human Estrogen Receptor {alpha} that Are Important for Modulating Transactivation and Protein-Protein Interactions.
A. Koide, C. Zhao, M. Naganuma, J. Abrams, S. Deighton-Collins, D. F. Skafar, and S. Koide (2007)
Mol. Endocrinol. 21, 829-842
   Abstract »    Full Text »    PDF »
Raloxifene and ICI182,780 Increase Estrogen Receptor-{alpha} Association with a Nuclear Compartment via Overlapping Sets of Hydrophobic Amino Acids in Activation Function 2 Helix 12.
M. Lupien, M. Jeyakumar, E. Hebert, K. Hilmi, D. Cotnoir-White, C. Loch, A. Auger, G. Dayan, G.-A. Pinard, J.-M. Wurtz, et al. (2007)
Mol. Endocrinol. 21, 797-816
   Abstract »    Full Text »    PDF »
In Vitro Fluorescence Anisotropy Analysis of the Interaction of Full-length SRC1a with Estrogen Receptors {alpha} and beta Supports an Active Displacement Model for Coregulator Utilization.
S. Wang, C. Zhang, S. K. Nordeen, and D. J. Shapiro (2007)
J. Biol. Chem. 282, 2765-2775
   Abstract »    Full Text »    PDF »
Definition of the Molecular Basis for Estrogen Receptor-Related Receptor-{alpha}-Cofactor Interactions.
S. Gaillard, M. A. Dwyer, and D. P. McDonnell (2007)
Mol. Endocrinol. 21, 62-76
   Abstract »    Full Text »    PDF »
Mechanism-based discovery as an approach to identify the next generation of estrogen receptor modulators.
D. P. McDonnell (2006)
FASEB J 20, 2432-2434
   Full Text »    PDF »
Linking Ligand-Induced Alterations in Androgen Receptor Structure to Differential Gene Expression: A First Step in the Rational Design of Selective Androgen Receptor Modulators.
D. Kazmin, T. Prytkova, C. E. Cook, R. Wolfinger, T.-M. Chu, D. Beratan, J. D. Norris, C.-y. Chang, and D. P. McDonnell (2006)
Mol. Endocrinol. 20, 1201-1217
   Abstract »    Full Text »    PDF »
Coregulators in Nuclear Estrogen Receptor Action: From Concept to Therapeutic Targeting.
J. M. Hall and D. P. McDonnell (2005)
Mol. Interv. 5, 343-357
   Abstract »    Full Text »    PDF »
Development of Peptide Antagonists for the Androgen Receptor Using Combinatorial Peptide Phage Display.
C.-y. Chang, J. Abdo, T. Hartney, and D. P. McDonnell (2005)
Mol. Endocrinol. 19, 2478-2490
   Abstract »    Full Text »    PDF »
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17.
P. E. Goss, J. N. Ingle, S. Martino, N. J. Robert, H. B. Muss, M. J. Piccart, M. Castiglione, D. Tu, L. E. Shepherd, K. I. Pritchard, et al. (2005)
J Natl Cancer Inst 97, 1262-1271
   Abstract »    Full Text »    PDF »
Peptide Binding Identifies an ER{alpha} Conformation That Generates Selective Activity in Multiple In Vitro Assays.
C. J. Larson, D. L. Osburn, K. Schmitz, L. Giampa, S.-M. Mong, K. Marschke, H. M. Seidel, J. Rosen, and A. Negro-Vilar (2005)
J Biomol Screen 10, 590-598
   Abstract »    PDF »
High-Dose Estrogen and Clinical Selective Estrogen Receptor Modulators Induce Growth Arrest, p21, and p53 in Primate Ovarian Surface Epithelial Cells.
J. W. Wright, R. L. Stouffer, and K. D. Rodland (2005)
J. Clin. Endocrinol. Metab. 90, 3688-3695
   Abstract »    Full Text »    PDF »
Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor.
E. H. Kong, N. Heldring, J.-A. Gustafsson, E. Treuter, R. E. Hubbard, and A. C. W. Pike (2005)
PNAS 102, 3593-3598
   Abstract »    Full Text »    PDF »
The Molecular Pharmacology of Estrogen Receptor Modulators: Implications for the Treatment of Breast Cancer.
D. P. McDonnell (2005)
Clin. Cancer Res. 11, 871s-877s
   Abstract »    Full Text »    PDF »
Characterization of the Interaction between Retinoic Acid Receptor/Retinoid X Receptor (RAR/RXR) Heterodimers and Transcriptional Coactivators through Structural and Fluorescence Anisotropy Studies.
V. Pogenberg, J.-F. Guichou, V. Vivat-Hannah, S. Kammerer, E. Perez, P. Germain, A. R. de Lera, H. Gronemeyer, C. A. Royer, and W. Bourguet (2005)
J. Biol. Chem. 280, 1625-1633
   Abstract »    Full Text »    PDF »
Analysis of Ligand-Dependent Recruitment of Coactivator Peptides to Estrogen Receptor Using Fluorescence Polarization.
M. S. Ozers, K. M. Ervin, C. L. Steffen, J. A. Fronczak, C. S. Lebakken, K. A. Carnahan, R. G. Lowery, and T. J. Burke (2005)
Mol. Endocrinol. 19, 25-34
   Abstract »    Full Text »    PDF »
Rapid isolation of high-affinity protein binding peptides using bacterial display.
P. H. Bessette, J. J. Rice, and P. S. Daugherty (2004)
Protein Eng. Des. Sel. 17, 731-739
   Abstract »    Full Text »    PDF »
Correlation between in Vitro Peptide Binding Profiles and Cellular Activities for Estrogen Receptor-Modulating Compounds.
M. A. Iannone, C. A. Simmons, S. H. Kadwell, D. L. Svoboda, D. E. Vanderwall, S.-J. Deng, T. G. Consler, J. Shearin, J. G. Gray, and K. H. Pearce (2004)
Mol. Endocrinol. 18, 1064-1081
   Abstract »    Full Text »    PDF »
Identification of Tamoxifen-Induced Coregulator Interaction Surfaces within the Ligand-Binding Domain of Estrogen Receptors.
N. Heldring, M. Nilsson, B. Buehrer, E. Treuter, and J.-A. Gustafsson (2004)
Mol. Cell. Biol. 24, 3445-3459
   Abstract »    Full Text »    PDF »
Selective Estrogen Receptor Modulators: Discrimination of Agonistic versus Antagonistic Activities by Gene Expression Profiling in Breast Cancer Cells.
J. Frasor, F. Stossi, J. M. Danes, B. Komm, C. R. Lyttle, and B. S. Katzenellenbogen (2004)
Cancer Res. 64, 1522-1533
   Abstract »    Full Text »    PDF »
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators.
C. L. Smith and B. W. O'Malley (2004)
Endocr. Rev. 25, 45-71
   Abstract »    Full Text »    PDF »
A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer.
P. E. Goss, J. N. Ingle, S. Martino, N. J. Robert, H. B. Muss, M. J. Piccart, M. Castiglione, D. Tu, L. E. Shepherd, K. I. Pritchard, et al. (2003)
N. Engl. J. Med. 349, 1793-1802
   Abstract »    Full Text »    PDF »
Mining the Complexities of the Estrogen Signaling Pathways for Novel Therapeutics.
D. P. McDonnell (2003)
Endocrinology 144, 4237-4240
   Full Text »    PDF »
Various Phosphorylation Pathways, Depending on Agonist and Antagonist Binding to Endogenous Estrogen Receptor {alpha} (ER{alpha}), Differentially Affect ER{alpha} Extractability, Proteasome-Mediated Stability, and Transcriptional Activity in Human Breast Cancer Cells.
V. Marsaud, A. Gougelet, S. Maillard, and J.-M. Renoir (2003)
Mol. Endocrinol. 17, 2013-2027
   Abstract »    Full Text »    PDF »
Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions.
A.-M. Leduc, J. O. Trent, J. L. Wittliff, K. S. Bramlett, S. L. Briggs, N. Y. Chirgadze, Y. Wang, T. P. Burris, and A. F. Spatola (2003)
PNAS 100, 11273-11278
   Abstract »    Full Text »    PDF »
Nuclear Coactivator-62 kDa/Ski-interacting Protein Is a Nuclear Matrix-associated Coactivator That May Couple Vitamin D Receptor-mediated Transcription and RNA Splicing.
C. Zhang, D. R. Dowd, A. Staal, C. Gu, J. B. Lian, A. J. van Wijnen, G. S. Stein, and P. N. MacDonald (2003)
J. Biol. Chem. 278, 35325-35336
   Abstract »    Full Text »    PDF »
The Use of Phage Display Technique for the Isolation of Androgen Receptor Interacting Peptides with (F/W)XXL(F/W) and FXXLY New Signature Motifs.
C.-L. Hsu, Y.-L. Chen, S. Yeh, H.-J. Ting, Y.-C. Hu, H. Lin, X. Wang, and C. Chang (2003)
J. Biol. Chem. 278, 23691-23698
   Abstract »    Full Text »    PDF »
The cis Decoy against the Estrogen Response Element Suppresses Breast Cancer Cells via Target Disrupting c-fos not Mitogen-activated Protein Kinase Activity.
L. H. Wang, X. Y. Yang, X. Zhang, K. Mihalic, W. Xiao, and W. L. Farrar (2003)
Cancer Res. 63, 2046-2051
   Abstract »    Full Text »    PDF »
Use of Real-Time Polymerase Chain Reaction to Identify Cell- and Tissue-Type-Selective Peptides by Phage Display.
D. L. Jaye, F. S. Nolte, L. Mazzucchelli, C. Geigerman, A. Akyildiz, and C. A. Parkos (2003)
Am. J. Pathol. 162, 1419-1429
   Abstract »    Full Text »    PDF »
Smad4 as a Transcription Corepressor for Estrogen Receptor alpha.
L. Wu, Y. Wu, B. Gathings, M. Wan, X. Li, W. Grizzle, Z. Liu, C. Lu, Z. Mao, and X. Cao (2003)
J. Biol. Chem. 278, 15192-15200
   Abstract »    Full Text »    PDF »
Hierarchical Affinities and a Bipartite Interaction Model for Estrogen Receptor Isoforms and Full-length Steroid Receptor Coactivator (SRC/p160) Family Members.
B. J. Cheskis, N. J. McKenna, C.-W. Wong, J. Wong, B. Komm, C. R. Lyttle, and B. W. O'Malley (2003)
J. Biol. Chem. 278, 13271-13277
   Abstract »    Full Text »    PDF »
Isoform-Selective Interactions between Estrogen Receptors and Steroid Receptor Coactivators Promoted by Estradiol and ErbB-2 Signaling in Living Cells.
Y. Bai and V. Giguere (2003)
Mol. Endocrinol. 17, 589-599
   Abstract »    Full Text »    PDF »
Differential SERM Effects on Corepressor Binding Dictate ERalpha Activity in Vivo.
P. Webb, P. Nguyen, and P. J. Kushner (2003)
J. Biol. Chem. 278, 6912-6920
   Abstract »    Full Text »    PDF »
Selective Estrogen-Receptor Modulators -- Mechanisms of Action and Application to Clinical Practice.
B. L. Riggs and L. C. Hartmann (2003)
N. Engl. J. Med. 348, 618-629
   Full Text »    PDF »
Regulation of Nuclear Receptor Transcriptional Activity by a Novel DEAD Box RNA Helicase (DP97).
R. R. Rajendran, A. C. Nye, J. Frasor, R. D. Balsara, P. G. V. Martini, and B. S. Katzenellenbogen (2003)
J. Biol. Chem. 278, 4628-4638
   Abstract »    Full Text »    PDF »
Phage-displayed Peptides Bind to the Malarial Protein Apical Membrane Antigen-1 and Inhibit the Merozoite Invasion of Host Erythrocytes.
F. Li, A. Dluzewski, A. M. Coley, A. Thomas, L. Tilley, R. F. Anders, and M. Foley (2002)
J. Biol. Chem. 277, 50303-50310
   Abstract »    Full Text »    PDF »
Novel Mechanism of Nuclear Receptor Corepressor Interaction Dictated by Activation Function 2 Helix Determinants.
A. N. Moraitis, V. Giguere, and C. C. Thompson (2002)
Mol. Cell. Biol. 22, 6831-6841
   Abstract »    Full Text »    PDF »
Identification and Characterization of Novel Estrogen Receptor-{beta}-Sparing Antiprogestins.
G. Sathya, M. S. Jansen, S. C. Nagel, C. E. Cook, and D. P. MCDonnell (2002)
Endocrinology 143, 3071-3082
   Abstract »    Full Text »    PDF »
Minireview: Nuclear Receptor Coactivators--An Update.
N. J. McKenna and B. W. O'Malley (2002)
Endocrinology 143, 2461-2465
   Abstract »    Full Text »    PDF »
Estrogen Receptor {alpha} Inhibits IL-1{beta} Induction of Gene Expression in the Mouse Liver.
M. J. Evans, K. Lai, L. J. Shaw, D. C. Harnish, and C. C. Chadwick (2002)
Endocrinology 143, 2559-2570
   Abstract »    Full Text »    PDF »
Ovariectomy upregulates expression of estrogen receptors, NOS, and HSPs in porcine platelets.
M. Jayachandran and V. M. Miller (2002)
Am J Physiol Heart Circ Physiol 283, H220-H226
   Abstract »    Full Text »    PDF »
pS2 Gene Expression in HepG2 cells: Complex Regulation through Crosstalk between the Estrogen Receptor alpha , an Estrogen-Responsive Element, and the Activator Protein 1 Response Element.
T. Barkhem, L.-A. Haldosen, J.-A. Gustafsson, and S. Nilsson (2002)
Mol. Pharmacol. 61, 1273-1283
   Abstract »    Full Text »    PDF »
Calmodulin Is a Selective Modulator of Estrogen Receptors.
J. M. Garcia Pedrero, B. del Rio, C. Martinez-Campa, M. Muramatsu, P. S. Lazo, and S. Ramos (2002)
Mol. Endocrinol. 16, 947-960
   Abstract »    Full Text »    PDF »
Evaluation of Ligand-Dependent Changes in AR Structure Using Peptide Probes.
C.-Y. Chang and D. P. McDonnell (2002)
Mol. Endocrinol. 16, 647-660
   Abstract »    Full Text »    PDF »
Identification of Novel Non-phosphorylated Ligands, Which Bind Selectively to the SH2 Domain of Grb7.
S. C. Pero, L. Oligino, R. J. Daly, A. L. Soden, C. Liu, P. P. Roller, P. Li, and D. N. Krag (2002)
J. Biol. Chem. 277, 11918-11926
   Abstract »    Full Text »    PDF »
A Negative Coregulator for the Human ER.
J. D. Norris, D. Fan, A. Sherk, and D. P. McDonnell (2002)
Mol. Endocrinol. 16, 459-468
   Abstract »    Full Text »    PDF »
Allosteric Regulation of Estrogen Receptor Structure, Function, and Coactivator Recruitment by Different Estrogen Response Elements.
J. M. Hall, D. P. McDonnell, and K. S. Korach (2002)
Mol. Endocrinol. 16, 469-486
   Abstract »    Full Text »    PDF »
Ligand-Selective Interactions of ER Detected in Living Cells by Fluorescence Resonance Energy Transfer.
R. V. Weatherman, C.-Y. Chang, N. J. Clegg, D. C. Carroll, R. N. Day, J. D. Baxter, D. P. McDonnell, T. S. Scanlan, and F. Schaufele (2002)
Mol. Endocrinol. 16, 487-496
   Abstract »    Full Text »    PDF »
The Dawn of the SPPARMs?.
S. M. Rangwala and M. A. Lazar (2002)
Sci. STKE 2002, pe9
   Abstract »    Full Text »    PDF »
Probing protein conformational changes in living cells by using designer binding proteins: Application to the estrogen receptor.
A. Koide, S. Abbatiello, L. Rothgery, and S. Koide (2002)
PNAS
   Abstract »    Full Text »    PDF »
Ser-884 Adjacent to the LXXLL Motif of Coactivator TRBP Defines Selectivity for ERs and TRs.
L. Ko, G. R. Cardona, T. Iwasaki, K. S. Bramlett, T. P. Burris, and W. W. Chin (2002)
Mol. Endocrinol. 16, 128-140
   Abstract »    Full Text »    PDF »
Definition of the Molecular and Cellular Mechanisms Underlying the Tissue-selective Agonist/Antagonist Activities of Selective Estrogen Receptor Modulators.
D. P. McDonnell, C. E. Connor, A. Wijayaratne, C.-y. Chang, and J. D. Norris (2002)
Recent Prog. Horm. Res. 57, 295-316
   Abstract »    Full Text »    PDF »
Selective Estrogen Receptor Modulation and Reduction in Risk of Breast Cancer, Osteoporosis, and Coronary Heart Disease.
V. C. Jordan, S. Gapstur, and M. Morrow (2001)
J Natl Cancer Inst 93, 1449-1457
   Abstract »    Full Text »    PDF »
Mechanisms of Estrogen Action.
S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, and J.-A. Gustafsson (2001)
Physiol Rev 81, 1535-1565
   Abstract »    Full Text »    PDF »
A New Antiestrogen, 2-(4-Hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), Inhibits the Growth of Tamoxifen-sensitive and -resistant Tumors and Is Devoid of Uterotropic Effects in Mice and Rats.
L. M. Greenberger, T. Annable, K. I. Collins, B. S. Komm, C. R. Lyttle, C. P. Miller, P. G. Satyaswaroop, Y. Zhang, and P. Frost (2001)
Clin. Cancer Res. 7, 3166-3177
   Abstract »    Full Text »    PDF »
Effects of Estrogen on the Vascular Injury Response in Estrogen Receptor {alpha},{beta} (Double) Knockout Mice.
R. H. Karas, H. Schulten, G. Pare, M. J. Aronovitz, C. Ohlsson, J.-A. Gustafsson, and M. E. Mendelsohn (2001)
Circ. Res. 89, 534-539
   Abstract »    Full Text »    PDF »
Analysis of Cross-Resistance of the Selective Estrogen Receptor Modulators Arzoxifene (LY353381) and LY117018 in Tamoxifen-stimulated Breast Cancer Xenografts.
J. M. Schafer, E.-S. Lee, R. C. Dardes, D. Bentrem, R. M. O'Regan, A. De Los Reyes, and V. C. Jordan (2001)
Clin. Cancer Res. 7, 2505-2512
   Abstract »    Full Text »    PDF »
Perspective: Female Steroid Hormone Action.
O. M. Conneely (2001)
Endocrinology 142, 2194-2199
   Full Text »    PDF »
Silencing and Reactivation of the Selective Estrogen Receptor Modulator-Estrogen Receptor {{alpha}} Complex.
H. Liu, E.-S. Lee, A. D. L. Reyes, J. W. Zapf, and V. C. Jordan (2001)
Cancer Res. 61, 3632-3639
   Abstract »    Full Text »
Phase I Study of a Third-Generation Selective Estrogen Receptor Modulator, LY353381.HCl, in Metastatic Breast Cancer.
P. N. Munster, A. Buzdar, K. Dhingra, N. Enas, L. Ni, M. Major, A. Melemed, A. Seidman, D. Booser, R. Theriault, et al. (2001)
J. Clin. Oncol. 19, 2002-2009
   Abstract »    Full Text »    PDF »
Circumventing Tamoxifen Resistance in Breast Cancers Using Antiestrogens That Induce Unique Conformational Changes in the Estrogen Receptor.
C. E. Connor, J. D. Norris, G. Broadwater, T. M. Willson, M. M. Gottardis, M. W. Dewhirst, and D. P. McDonnell (2001)
Cancer Res. 61, 2917-2922
   Abstract »    Full Text »
Molecular Mechanism of Action at Estrogen Receptor {{alpha}} of a New Clinically Relevant Antiestrogen (GW7604) Related to Tamoxifen.
D. J. Bentrem, R. C. Dardes, H. Liu, J. MacGregor-Schafer, J. W. Zapf, and V. C. Jordan (2001)
Endocrinology 142, 838-846
   Abstract »    Full Text »    PDF »
CIA, a Novel Estrogen Receptor Coactivator with a Bifunctional Nuclear Receptor Interacting Determinant.
F. Sauve, L. D. B. McBroom, J. Gallant, A. N. Moraitis, F. Labrie, and V. Giguere (2001)
Mol. Cell. Biol. 21, 343-353
   Abstract »    Full Text »    PDF »
Temporally Distinct and Ligand-Specific Recruitment of Nuclear Receptor-Interacting Peptides and Cofactors to Subnuclear Domains Containing the Estrogen Receptor.
F. Schaufele, C.-y. Chang, W. Liu, J. D. Baxter, S. K. Nordeen, Y. Wan, R. N. Day, and D. P. McDonnell (2000)
Mol. Endocrinol. 14, 2024-2039
   Abstract »    Full Text »
Molecular Mechanisms of Selective Estrogen Receptor Modulator (SERM) Action.
M. Dutertre and C. L. Smith (2000)
J. Pharmacol. Exp. Ther. 295, 431-437
   Abstract »    Full Text »
Conformational Changes and Coactivator Recruitment by Novel Ligands for Estrogen Receptor-{alpha} and Estrogen Receptor-{beta}: Correlations with Biological Character and Distinct Differences among SRC Coactivator Family Members.
D. M. Kraichely, J. Sun, J. A. Katzenellenbogen, and B. S. Katzenellenbogen (2000)
Endocrinology 141, 3534-3545
   Abstract »    Full Text »    PDF »
Allosteric Silencing of Activating Function 1 in the 4-Hydroxytamoxifen Estrogen Receptor Complex Is Induced by Substituting Glycine for Aspartate at Amino Acid 351.
J. M. Schafer, H. Liu, D. J. Bentrem, J. W. Zapf, and V. C. Jordan (2000)
Cancer Res. 60, 5097-5105
   Abstract »    Full Text »
The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding.
P. H. Giangrande, E. A. Kimbrel, D. P. Edwards, and D. P. McDonnell (2000)
Mol. Cell. Biol. 20, 3102-3115
   Abstract »    Full Text »    PDF »
Selection of Estrogen Receptor {beta}- and Thyroid Hormone Receptor {beta}-Specific Coactivator-Mimetic Peptides Using Recombinant Peptide Libraries.
J. P. Northrop, D. Nguyen, S. Piplani, S. E. Olivan, S. T-S. Kwan, N. F. Go, C. P. Hart, and P. J. Schatz (2000)
Mol. Endocrinol. 14, 605-622
   Abstract »    Full Text »
Ligand-, Cell-, and Estrogen Receptor Subtype (alpha /beta )-dependent Activation at GC-rich (Sp1) Promoter Elements.
B. Saville, M. Wormke, F. Wang, T. Nguyen, E. Enmark, G. Kuiper, J.-A. Gustafsson, and S. Safe (2000)
J. Biol. Chem. 275, 5379-5387
   Abstract »    Full Text »    PDF »
Molecular determinants of nuclear receptor-corepressor interaction.
V. Perissi, L. M. Staszewski, E. M. McInerney, R. Kurokawa, A. Krones, D. W. Rose, M. H. Lambert, M. V. Milburn, C. K. Glass, and M. G. Rosenfeld (1999)
Genes & Dev. 13, 3198-3208
   Abstract »    Full Text »
Dissection of the LXXLL Nuclear Receptor-Coactivator Interaction Motif Using Combinatorial Peptide Libraries: Discovery of Peptide Antagonists of Estrogen Receptors alpha and beta.
C.-y. Chang, J. D. Norris, H. Gron, L. A. Paige, P. T. Hamilton, D. J. Kenan, D. Fowlkes, and D. P. McDonnell (1999)
Mol. Cell. Biol. 19, 8226-8239
   Abstract »    Full Text »    PDF »
Tamoxifen Prevention of Breast Cancer: an Instance of the Fingerpost.
S. M. Lippman and P. H. Brown (1999)
J Natl Cancer Inst 91, 1809-1819
   Full Text »    PDF »
Analysis of Estrogen Receptor Interaction with a Repressor of Estrogen Receptor Activity (REA) and the Regulation of Estrogen Receptor Transcriptional Activity by REA.
R. Delage-Mourroux, P. G. V. Martini, I. Choi, D. M. Kraichely, J. Hoeksema, and B. S. Katzenellenbogen (2000)
J. Biol. Chem. 275, 35848-35856
   Abstract »    Full Text »    PDF »
Modulation of Estrogen Receptor-alpha Transcriptional Activity by the Coactivator PGC-1.
I. Tcherepanova, P. Puigserver, J. D. Norris, B. M. Spiegelman, and D. P. McDonnell (2000)
J. Biol. Chem. 275, 16302-16308
   Abstract »    Full Text »    PDF »
Identification and Characterization of a Novel Factor That Regulates Quinone Reductase Gene Transcriptional Activity.
M. M. Montano, B. M. Wittmann, and N. R. Bianco (2000)
J. Biol. Chem. 275, 34306-34313
   Abstract »    Full Text »    PDF »
Nerve Growth Factor (NGF) Loop 4 Dimeric Mimetics Activate ERK and AKT and Promote NGF-like Neurotrophic Effects.
Y. Xie, M. A. Tisi, T. T. Yeo, and F. M. Longo (2000)
J. Biol. Chem. 275, 29868-29874
   Abstract »    Full Text »    PDF »
Unique Protein Determinants of the Subtype-selective Ligand Responses of the Estrogen Receptors (ERalpha and ERbeta ) at AP-1 Sites.
R. V. Weatherman and T. S. Scanlan (2001)
J. Biol. Chem. 276, 3827-3832
   Abstract »    Full Text »    PDF »
An Antiestrogen-responsive Estrogen Receptor-alpha Mutant (D351Y) Shows Weak AF-2 Activity in the Presence of Tamoxifen.
P. Webb, P. Nguyen, C. Valentine, R. V. Weatherman, T. S. Scanlan, and P. J. Kushner (2000)
J. Biol. Chem. 275, 37552-37558
   Abstract »    Full Text »    PDF »
Differential Recruitment of the Mammalian Mediator Subunit TRAP220 by Estrogen Receptors ERalpha and ERbeta.
A. Warnmark, T. Almlof, J. Leers, J.-A. Gustafsson, and E. Treuter (2001)
J. Biol. Chem. 276, 23397-23404
   Abstract »    Full Text »    PDF »
Acyl-CoA Esters Antagonize the Effects of Ligands on Peroxisome Proliferator-activated Receptor alpha Conformation, DNA Binding, and Interaction with Co-factors.
M. Elholm, I. Dam, C. Jorgensen, A.-M. Krogsdam, D. Holst, I. Kratchmarova, M. Gottlicher, J.-A. Gustafsson, R. Berge, T. Flatmark, et al. (2001)
J. Biol. Chem. 276, 21410-21416
   Abstract »    Full Text »    PDF »
The Human Estrogen Receptor-alpha Is a Ubiquitinated Protein Whose Stability Is Affected Differentially by Agonists, Antagonists, and Selective Estrogen Receptor Modulators.
A. L. Wijayaratne and D. P. McDonnell (2001)
J. Biol. Chem. 276, 35684-35692
   Abstract »    Full Text »    PDF »
Ternary Complexes and Cooperative Interplay between NCoA-62/Ski-interacting Protein and Steroid Receptor Coactivators in Vitamin D Receptor-mediated Transcription.
C. Zhang, T. A. Baudino, D. R. Dowd, H. Tokumaru, W. Wang, and P. N. MacDonald (2001)
J. Biol. Chem. 276, 40614-40620
   Abstract »    Full Text »    PDF »
The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling.
J. M. Hall, J. F. Couse, and K. S. Korach (2001)
J. Biol. Chem. 276, 36869-36872
   Full Text »    PDF »
Probing protein conformational changes in living cells by using designer binding proteins: Application to the estrogen receptor.
A. Koide, S. Abbatiello, L. Rothgery, and S. Koide (2002)
PNAS 99, 1253-1258
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)